News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
168,871 Results
Type
Article (6797)
Company Profile (110)
Press Release (161964)
Section
Business (53836)
Career Advice (355)
Deals (9765)
Drug Delivery (30)
Drug Development (31969)
Employer Resources (68)
FDA (2727)
Job Trends (4138)
News (96517)
Policy (6752)
Tag
2024 BioCapital Digital (3)
2024 BioForest Digital (1)
2024 BioForest Standard (1)
2024 BioMidwest Digital (4)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (3)
2024 Biotech Bay Standard (6)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (1)
2026 BioMidwest Elite (1)
2026 Biotech Bay Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Pharm Country Elite (1)
Academia (256)
Adcomms (2)
Allergies (25)
Alliances (12270)
ALS (28)
Alzheimer's disease (376)
Antibody-drug conjugate (ADC) (48)
Approvals (2742)
Artificial intelligence (63)
Autoimmune disease (5)
Automation (1)
Bankruptcy (63)
Best Places to Work (3219)
BIOSECURE Act (14)
Biosimilars (34)
Biotechnology (72)
Bladder cancer (15)
Brain cancer (13)
Breast cancer (49)
Cancer (551)
Cardiovascular disease (33)
Career advice (303)
Career pathing (20)
CAR-T (50)
Cell therapy (123)
Cervical cancer (3)
Clinical research (26917)
Collaboration (242)
Compensation (219)
Complete response letters (7)
COVID-19 (651)
CRISPR (7)
C-suite (84)
Cystic fibrosis (25)
Data (623)
Decentralized trials (1)
Denatured (12)
Depression (14)
Diabetes (54)
Diagnostics (601)
Digital health (2)
Diversity (6)
Diversity, equity & inclusion (19)
Drug discovery (25)
Drug pricing (22)
Drug shortages (3)
Duchenne muscular dystrophy (14)
Earnings (22871)
Editorial (21)
Employer branding (10)
Employer resources (59)
Events (33673)
Executive appointments (262)
FDA (3007)
Featured Employer (22)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (175)
Gene editing (16)
Generative AI (9)
Gene therapy (61)
GLP-1 (233)
Government (721)
Guidances (14)
Healthcare (2307)
Huntington's disease (9)
IgA nephropathy (7)
Immunology and inflammation (28)
Indications (10)
Infectious disease (679)
Inflammatory bowel disease (44)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (32)
Interviews (58)
IPO (5762)
IRA (14)
Job creations (1025)
Job search strategy (260)
Kidney cancer (5)
Labor market (19)
Layoffs (122)
Leadership (11)
Legal (909)
Liver cancer (22)
Lung cancer (92)
Lymphoma (34)
Machine learning (2)
Management (22)
Manufacturing (98)
MASH (34)
Medical device (442)
Medtech (443)
Mergers & acquisitions (4204)
Metabolic disorders (197)
Multiple sclerosis (24)
NASH (8)
Neurodegenerative disease (24)
Neuropsychiatric disorders (7)
Neuroscience (525)
NextGen: Class of 2025 (979)
Non-profit (239)
Northern California (927)
Now hiring (26)
Obesity (102)
Opinion (76)
Ovarian cancer (26)
Pain (21)
Pancreatic cancer (17)
Parkinson's disease (33)
Partnered (1)
Patents (60)
Patient recruitment (32)
Peanut (14)
People (17161)
Pharmaceutical (38)
Pharmacy benefit managers (1)
Phase I (8143)
Phase II (12412)
Phase III (9038)
Pipeline (345)
Podcasts (42)
Policy (52)
Postmarket research (510)
Preclinical (3028)
Press Release (19)
Prostate cancer (19)
Psychedelics (12)
Radiopharmaceuticals (109)
Rare diseases (92)
Real estate (1199)
Recruiting (28)
Regulatory (5641)
Reports (22)
Research institute (280)
Resumes & cover letters (40)
RSV (10)
Schizophrenia (34)
Series A (33)
Series B (19)
Service/supplier (4)
Sickle cell disease (8)
Southern California (727)
Special edition (15)
Sponsored (5)
Startups (958)
State (1)
Stomach cancer (1)
Supply chain (14)
The Weekly (30)
United States (6972)
Vaccines (146)
Venture capitalists (15)
Webinars (7)
Weight loss (55)
Women's health (7)
Worklife (9)
Date
Today (60)
Last 7 days (298)
Last 30 days (1091)
Last 365 days (12255)
2025 (2057)
2024 (12551)
2023 (14345)
2022 (16202)
2021 (17842)
2020 (15212)
2019 (10002)
2018 (7150)
2017 (8954)
2016 (7309)
2015 (9305)
2014 (7062)
2013 (5085)
2012 (4916)
2011 (4844)
2010 (4810)
Location
Africa (165)
Alabama (18)
Arizona (17)
Arkansas (2)
Asia (13452)
Australia (1472)
California (1934)
Canada (461)
China (258)
Colorado (72)
Connecticut (82)
Delaware (64)
Europe (24377)
Florida (241)
Georgia (55)
Idaho (3)
Illinois (93)
India (5)
Indiana (70)
Iowa (3)
Japan (51)
Kansas (49)
Kentucky (7)
Maine (2)
Maryland (211)
Massachusetts (1563)
Michigan (34)
Minnesota (68)
Missouri (15)
Nebraska (6)
Nevada (4)
New Hampshire (4)
New Jersey (693)
New Mexico (7)
New York (661)
North Carolina (327)
Northern California (927)
Ohio (63)
Oklahoma (3)
Oregon (12)
Pennsylvania (349)
Puerto Rico (3)
Rhode Island (6)
South America (209)
Southern California (727)
Tennessee (8)
Texas (194)
Utah (45)
Virginia (36)
Washington D.C. (12)
Washington State (133)
Wisconsin (9)
168,871 Results for "synageva biopharma".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Job Trends
Getting Jobs Outside of Major Biopharma Hubs Proves Tough,
BioSpace
Finds
Over 80% of those living outside of biopharma’s biggest hubs, like San Diego or Boston, have a tough time finding work, according to a
BioSpace
LinkedIn poll. Biopharma professionals in Oregon and Connecticut and a
BioSpace
recruitment manager share their insights on this issue.
February 27, 2025
·
6 min read
·
Angela Gabriel
Bankruptcy
Biopharma Bankruptcies Still At Peak, With Little Relief in Sight
2023 marked the most bankruptcies in biopharma in more than a decade, with 14 companies filing for Chapter 11 protection. The number remained high in 2024.
February 19, 2025
·
5 min read
·
Annalee Armstrong
NextGen
BioSpace
’s NextGen Class of 2025 Leans Into Biopharma’s Hottest Trends
From ADCs and radiopharmaceuticals to cell and gene therapies, eager young startups are betting on advances in biopharma’s most competitive therapeutic spaces—and attracting dollars from Big Pharma.
January 7, 2025
·
5 min read
·
Heather McKenzie
Career Advice
The Top 12 Companies Hiring in Biopharma Now
Looking for a biopharma job? Check out the
BioSpace
list of 12 top companies hiring life sciences professionals like you.
February 6, 2025
·
1 min read
·
Angela Gabriel
Interviews
The 4 Biggest Job Interview Mistakes Biopharma Professionals Make
As they navigate a competitive job market, biopharma professionals are making four key interview mistakes, according to two talent acquisition experts. They discuss those errors and offer tips for how to get those critical conversations right.
February 27, 2025
·
6 min read
·
Angela Gabriel
Collaboration
The Top 7 Biopharma Licensing Deals of 2024
Faced with the encroaching threats of patent expirations and generics, biopharma companies in 2024 invested 33% more in licensing deals, on average, than in 2023 with an eye toward enriching their pipelines with novel and potentially more effective therapies.
February 5, 2025
·
8 min read
·
Tristan Manalac
FDA
FDA Reels From ‘Indiscriminate’ Job Cuts Under Trump as Biopharma Appeals for Clarity
Morale is low at the FDA, which was hit with layoffs this week following RFK Jr.’s confirmation. Biopharma leaders and agency insiders fear further workforce cuts could delay new medicines.
February 20, 2025
·
5 min read
·
Heather McKenzie
Deals
The Biopharma Crystal Ball Comes Out at JPM25
Biopharma executives make their predictions for the year ahead, from a bold forecast for the return of the megadeal to a plea for the slow, healthy recovery of the industry at large.
January 17, 2025
·
3 min read
·
Annalee Armstrong
Manufacturing
Biopharma’s Big Question of 2024: Can You Scale It?
Suddenly the hottest thing in biopharma isn’t a new indication, disease target or modality—it’s manufacturing, and all of pharma is going to be vying for capacity and talent.
December 18, 2024
·
5 min read
·
Annalee Armstrong
Venture capitalists
The Megaround Ruled Biopharma in 2024 as First-Time VC Funding Doubled
Initial rounds of VC financing totaled $7.7 billion over 137 deals for biopharma in 2024, compared to $3.8 billion over 156 deals in 2023.
January 9, 2025
·
2 min read
·
Annalee Armstrong
1 of 16,888
Next
